zum Inhalt springen

Fachbereich Veterinärmedizin


Service-Navigation

    Publikationsdatenbank

    Use of viscous medium to study anthelmintic drug action in Caenorhabditis elegans (2024)

    Art
    Zeitschriftenartikel / wissenschaftlicher Beitrag
    Autoren
    Hellinga, Jacqueline R. (WE 13)
    Krücken, Jürgen (WE 13)
    Schulenburg, Hinrich
    von Samson-Himmelstjerna, Georg (WE 13)
    Quelle
    Scientific reports
    Bandzählung: 14
    Heftzählung: 1
    Seiten: 12756
    ISSN: 2045-2322
    Sprache
    Englisch
    Verweise
    URL (Volltext): https://www.nature.com/articles/s41598-024-63090-z
    DOI: 10.1038/s41598-024-63090-z
    Pubmed: 38830930
    Kontakt
    Institut für Parasitologie und Tropenveterinärmedizin

    Robert-von-Ostertag-Str. 7-13
    14163 Berlin
    +49 30 838 62310
    parasitologie@vetmed.fu-berlin.de

    Abstract / Zusammenfassung

    Caenorhabditis elegans is an appealing tool for experimental evolution and for working with antiparasitic drugs, from understanding the molecular mechanisms of drug action and resistance to uncover new drug targets. We present a new methodology for studying the impact of antiparasitic drugs in C. elegans. Viscous medium was initially designed for C. elegans maintenance during long-term evolution experiments. Viscous medium provides a less structured environment than the standard nematode growth media agar, yet the bacteria food source remains suspended. Further, the Viscous medium offers the worm population enough support to move freely, mate, and reproduce at a rate comparable to standard agar cultures. Here, the Viscous medium was adapted for use in antiparasitic research. We observed a similar sensitivity of C. elegans to anthelmintic drugs as in standard liquid media and statistical difference to the standard agar media through a larval development assay. Using Viscous medium in C. elegans studies will considerably improve antiparasitic resistance research, and this medium could be used in studies aimed at understanding long-term multigenerational drug activity.